Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
Kimberly-Clark is reportedly close to selling its Kleenex and international tissue operations to Brazil’s Suzano for approximately $3.5 billion, according to sources cited by The Wall Street Journal. The deal, expected to finalize as soon as Thursday, marks a strategic move in Kimberly-Clark’s global restructuring efforts.
The divestiture excludes North American operations and focuses on the company’s tissue businesses in other regions. The unit, generating around $500 million in annual EBITDA, was put up for sale in 2023. Kimberly-Clark’s goal has been to streamline its global operations amid rising costs and shifting market conditions.
In April, Reuters reported that Suzano, Royal Golden Eagle (RGE), and Asia Pulp & Paper (APP) were the final contenders for the international tissue division, which had been valued near $4 billion. Suzano, a major pulp and paper producer, previously acquired Kimberly-Clark’s Brazilian tissue operations in 2022.
The latest sale aligns with Kimberly-Clark’s strategy to focus on core markets as inflation and trade tariffs—particularly those imposed during President Donald Trump’s administration—have pressured profit margins. The company revised its annual earnings outlook in April due to elevated raw material and production costs tied to the tariffs.
Neither Kimberly-Clark (NYSE:KMB) nor Suzano responded to immediate requests for comment.
This move could significantly boost Suzano’s global footprint, particularly in the consumer tissue segment, while helping Kimberly-Clark reallocate resources and strengthen its position in the North American market. As global competition in consumer goods intensifies, strategic portfolio realignments like this one are expected to continue.
This high-profile acquisition highlights ongoing consolidation trends in the pulp and paper industry, with leading firms seeking economies of scale and global market share.
